Todd W. Garner
Net Worth

Last updated:

What is Todd W. Garner net worth?

The estimated net worth of Mr. Todd W. Garner is at least $11,294,152 as of 16 Aug 2023. He owns shares worth $60,768 as insider, has earned $6,274,384 from insider trading and has received compensation worth at least $4,959,000 in CONMED Corporation.

What is the salary of Todd W. Garner?

Mr. Todd W. Garner salary is $826,500 per year as Executive Vice President & Chief Financial Officer in CONMED Corporation.

How old is Todd W. Garner?

Mr. Todd W. Garner is 56 years old, born in 1969.

What stocks does Todd W. Garner currently own?

As insider, Mr. Todd W. Garner owns shares in one company:

Company Title Shares Price per share Total value
CONMED Corporation (CNMD) Executive Vice President & Chief Financial Officer 1,115 $54.5 $60,768

What does CONMED Corporation do?

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

CNMD logo
CNMD
CONMED Corporation
$54.5

Todd W. Garner insider trading

CONMED Corporation

Mr. Todd W. Garner has made 14 insider trades between 2019-2023, according to the Form 4 filled with the SEC. Most recently he sold 1,355 units of CNMD stock worth $151,760 on 16 Aug 2023.

The largest trade he's ever made was exercising 30,000 units of CNMD stock on 13 Mar 2023. As of 16 Aug 2023 he still owns at least 1,115 units of CNMD stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 1,355 $112 $151,760
Sale
Common Stock 1,300 $88.78 $115,417
Option
Options To Purchase Common Stock 30,000 $50.61 $1,518,300
Option
Common Stock 30,000 $50.61 $1,518,300
Sale
Common Stock 100 $92.63 $9,263
Sale
Common Stock 3,825 $91.95 $351,690
Sale
Common Stock 17,926 $91.1 $1,633,077
Sale
Common Stock 6,849 $90.3 $618,492
Sale
Common Stock 4,500 $89.31 $401,895
Option
Common Stock 4,500 $50.61 $227,745
Option
Options To Purchase Common Stock 4,500 $50.61 $227,745
Sale
Common Stock 2,662 $99.79 $265,641
Option
Rsus (restricted Stock Units) 1,600 N/A N/A
Option
Common Stock 1,600 N/A N/A
Option
Common Stock 2,000 N/A N/A
Option
Rsus (restricted Stock Units) 2,000 N/A N/A
Option
Options To Purchase Common Stock 8,400 $50.61 $425,124
Sale
Common Stock 8,559 $131.01 $1,121,332
Option
Common Stock 8,400 $50.61 $425,124
Sale
Common Stock 8,559 $131.01 $1,121,332
Sale
Common Stock 1,131 $124.92 $141,285
Sale
Common Stock 1,350 $122.76 $165,726
Sale
Common Stock 960 N/A N/A
Sale
Common Stock 1,257 $141.19 $177,476
Option
Common Stock 1,600 N/A N/A
Option
Rsus (restricted Stock Units) 1,600 N/A N/A
Option
Rsus (restricted Stock Units) 2,000 N/A N/A
Option
Common Stock 2,000 N/A N/A
Option
Rsus (restricted Stock Units) 1,600 N/A N/A
Option
Common Stock 1,600 N/A N/A
Option
Common Stock 2,000 N/A N/A
Option
Rsus (restricted Stock Units) 2,000 N/A N/A
Option
Rsus (restricted Stock Units) 2,000 N/A N/A
Option
Common Stock 2,000 N/A N/A

CONMED key executives

CONMED Corporation executives and other stock owners filed with the SEC:

  • Mr. Curt R. Hartman (61) Chairman, Chief Executive Officer & Pres
  • Mr. John E. Kennedy (67) Group Executive Vice President of Advanced Endoscopic Technologies, QA/RA, Distribution & Customer Service
  • Mr. Patrick J. Beyer (59) Pres of International & Global Orthopedics
  • Mr. Stanley W. Peters III (50) Vice President & GM of U.S. Advanced Surgical
  • Mr. Todd W. Garner (56) Executive Vice President & Chief Financial Officer